World's first malaria vaccine to benefit millions of children: UNICEF

UNITED NATIONS, Aug. 17: British pharmaceutical company GSK has been awarded a contract to produce the world's first malaria vaccine so that millions more children will be protected against the killer disease, the UN Children's Fund (UNICEF) announced on Tuesday.

The landmark award, valued at up to 170 million U.S. dollars, will lead to 18 million doses of the RTS,S vaccine available over the next three years, potentially saving thousands of young lives annually.